Clinton, NJ, United States of America

James C Towson

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Schering Corporation. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James C Towson. Retrieved from https://idiyas.com/inventor/james-c-towson-g5wx0gls

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: James C. Towson: Innovator in Pharmaceutical Intermediates

Introduction

James C. Towson is a notable inventor based in Clinton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of intermediates for florfenicol, an important antibiotic.

Latest Patents

James C. Towson holds 1 patent for a process that prepares a compound useful as an intermediate in the synthesis of florfenicol. His patent, titled "Process for preparing intermediates to florfenicol," outlines a method for creating a compound of formula I, where R and R' are defined within the patent documentation. This innovation plays a crucial role in the pharmaceutical industry by facilitating the production of florfenicol.

Career Highlights

Throughout his career, Towson has worked with prominent companies in the pharmaceutical sector. He has been associated with Schering Corporation and Merck Sharp & Dohme Corp., where he contributed to various projects and advancements in drug development.

Collaborations

James C. Towson has collaborated with Dhiru B. Vashi, a fellow professional in the field. Their partnership has likely fostered innovation and progress in their respective areas of expertise.

Conclusion

James C. Towson's work in developing processes for pharmaceutical intermediates highlights his valuable contributions to the industry. His patent for florfenicol intermediates exemplifies the importance of innovation in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…